Compare · head to head
GC Biopharma vs JW Pharmaceutical
JW Pharmaceutical ranks higher overall — 360 rank 95 vs 52.
JW Pharmaceutical leads on Value (69 vs 62), Quality (74 vs 67), Growth (56 vs 50) and Safety (61 vs 25). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7006280002 | KR7001060003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 52 | 95 |
| Value | 62 | 69 |
| Quality | 67 | 74 |
| Growth | 50 | 56 |
| Safety | 25 | 61 |
| Sentiment | 47 | 45 |
| Quality details | ||
| Profitability | 76 | 92 |
| Cash Truth | 58 | 55 |
GC Biopharma vs Green CrossGC Biopharma vs HandokGC Biopharma vs Chong Kun DangGC Biopharma vs Hanmi PharmaceuticalAdd a third stock →
Full analyses: GC Biopharma · JW Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100